Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Active implantable medical devices such as cardiac pacemaker systems, cochlear implants, implantable infusion pumps, cardiac resynchronization therapy devices aid in improving patient’s health and outcome of the medical treatment. Active implantable medical devices are prosthetic devices, which provide support in functioning of organs. For instance, pacemakers and defibrillators are capable of monitoring the heart rhythm. Pacemakers replace the natural pacemaker of the heart i.e. sinoatrial node (SA node) and defibrillator, monitors the heart rhythm and can prevent cardiac arrest. These devices come under Class II and some under Class III devices in the U.S. FDA medical devices listing and are subject to stringent regulations as they pose surgical risks during placement, bruising at surgical site, pain, and high risks due to implant failure. The active implantable medical devices market is dominated by few leading players such as Medtronic Plc., Abbott Laboratories, Boston Scientific Corporation, and Cochlear Ltd. accounting for over 70% of the market share.
Market Dynamics
Advancements in technology such as magnetic resonance imaging (MRI) compatible pacemakers and growing support in favor of use of such devices in cardiovascular and chronic pain diseases is expected to boost growth of the active implantable medical devices market. For instance, in November 2017, American Heart Association (AHA), the American College of Cardiology (ACC), and the Heart Rhythm Society (HRS) approved the use of subcutaneous implantable cardioverter defibrillator, (S-ICD), for the treatment of ventricular arrhythmias and to prevent cardiac arrest. Major manufacturers in the market are focusing on collaborations and mergers and acquisitions and are increasingly investing in research and development of implantable devices. For instance, merger of Sorin Group and Cyberonics to form LivaNova Plc in 2015. Furthermore, effectiveness of these devices in improving medical outcomes of cardiovascular and chronic pain diseases, absence of effective alternatives to these devices and continuous product launches is expected to fuel growth of the market.
Key features of the study:
This report provides in-depth analysis of active implantable medical devices market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global active implantable medical devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Cochlear Limited, Boston Scientific Corporation, Medtronic Plc, LivaNova Plc, Abbott laboratories, Sonova Holding AG, William Demant holding A/S, Nurotron Biotechnology Co., Ltd., and Med-EL
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global active implantable medical devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the active implantable medical devices market
Detailed Segmentation:
Global Active Implantable Medical Devices Market, By Product Type:
Pacemakers
Implantable Cardioverter Defibrillators (ICD)
Cardiac Resynchronization Therapy Devices (CRT-D)
Neurostimulators
Drug Infusion Pumps
Implantable Loop Recorders
Cochlear Implants
Others
Global Active Implantable Medical Devices Market, By Geography:
North America
By Product Type:
Pacemakers
Implantable Cardioverter Defibrillators (ICD)
Cardiac Resynchronization Therapy Devices (CRT-D)
Neurostimulators
Drug Infusion Pumps
Implantable Loop Recorders
Cochlear Implants
Others
By Country:
U.S.
Canada
Europe
By Product Type:
Pacemakers
Implantable Cardioverter Defibrillators (ICD)
Cardiac Resynchronization Therapy Devices (CRT-D)
Neurostimulators
Drug Infusion Pumps
Implantable Loop Recorders
Cochlear Implants
Others
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Pacemakers
Implantable Cardioverter Defibrillators (ICD)
Cardiac Resynchronization Therapy Devices (CRT-D)
Neurostimulators
Drug Infusion Pumps
Implantable Loop Recorders
Cochlear Implants
Others
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Product Type:
Pacemakers
Implantable Cardioverter Defibrillators (ICD)
Cardiac Resynchronization Therapy Devices (CRT-D)
Neurostimulators
Drug Infusion Pumps
Implantable Loop Recorders
Cochlear Implants
Others
By Country:
Brazil
Mexico
Rest of Latin America
Middle East
By Product Type:
Pacemakers
Implantable Cardioverter Defibrillators (ICD)
Cardiac Resynchronization Therapy Devices (CRT-D)
Neurostimulators
Drug Infusion Pumps
Implantable Loop Recorders
Cochlear Implants
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Pacemakers
Implantable Cardioverter Defibrillators (ICD)
Cardiac Resynchronization Therapy Devices (CRT-D)
Neurostimulators
Drug Infusion Pumps
Implantable Loop Recorders
Cochlear Implants
Others
By Country:
Central Africa
South Africa
North Africa
Company Profiles
Cochlear Limited*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Boston Scientific Corporation
Medtronic Plc.
LivaNova Plc.
Abbott Laboratories
Sonova Holding AG
William Demant holding A/S
Nurotron Biotechnology Co. Ltd.
Med-EL
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet, By Product Type
? Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
o Pricing Analysis
o PEST Analysis
o PORTER's Five Forces Analysis
o Regulatory Scenario
o Technological Evolution
4. Global Active Implantable Medical Devices Market, By Product Type, 2015-2025 (US$ Mn)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2016-2025
? Segment Trends
o Pacemakers
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Implantable Cardioverter Defibrillators (ICD)
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Cardiac Resynchronization Therapy Devices (CRT-D)
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Neurostimulators
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Drug Infusion Pumps
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Implantable Loop Recorders
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Cochlear Implants
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Others
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
5. Global Active Implantable Medical Devices Market, By Region, 2015-2025 (US$ Mn)
o Introduction
? Market Share Analysis, By Region, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, For Regions, 2016-2025
o North America
? Market Size and Forecast, By Product Type, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
? U.S.
? Canada
o Europe
? Market Size and Forecast, By Product Type, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
? U.K.
? Germany
? Italy
? France
? Spain
? Russia
? Rest of Europe
o Asia Pacific
? Market Size and Forecast, By Product Type, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
? China
? India
? Japan
? ASEAN
? Australia
? South Korea
? Rest of APAC
o Latin America
? Market Size and Forecast, By Product Type, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
? Brazil
? Mexico
? Rest of Latin America
o Africa
? Market Size and Forecast, By Product Type, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
? Central Africa
? South Africa
? North Africa
o Middle East
? Market Size and Forecast, By Product Type, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
? GCC
? Israel
? Rest of Middle East
6. Competitive Landscape
o Heat Map Analysis
o Company Profiles
? Cochlear Limited
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Boston Scientific Corporation
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Medtronic Plc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? LivaNova Plc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Abbott Laboratories
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Sonova Holding AG
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? William Demant holding A/S
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Nurotron Biotechnology Co. Ltd.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Med-EL
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
7. Section
o Research Methodology
o About us and Sales Contact
*Browse 30 market data tables and 56 figures on "Active Implantable Medical Devices Market - Global forecast to 2025".
